cancer-related fatigue (CRF)
Conditions
Interventions
Treatment group of the first stage:Acupuncture points selected are "Pi San Zhen" (Sishenzhen, bilateral Neiguan, bilateral Zusanli), once a day, five times a week (Monday to Friday morning).
Control group of the first stage:Psychotherapy interventions will be performed, including educational interventions (including CRF-related educational interventions, dietary guidance, sleep guidance),
Treatment group of the second stage:Acupuncture points selected are "Pi San Zhen" (Sishenzhen, bilateral Neiguan, bilateral Zusanli), once a day, three times a week (Monday, Wednesday and Friday morni
Control group of the second stage:No treatment.
Sponsors
Shanxi Province Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) The tumor was confirmed by imaging, pathology or cytology, and the clinical stage was clear; (2) Patients with KPS score =60 and identified as CRF by Piper-R score; (3) Age, sex and tumor species are unlimited; (4) Expected survival =3 months; (5) The subject must be conscious and cognitively capable of subjectively evaluating his feelings; (6) Informed consent to participate in the project study, sign the informed consent and be able to cooperate with the scale assessment.
Exclusion criteria
Exclusion criteria: (1) Conditions that may prevent subjects from completing the clinical trial process, including but not limited to serious and difficult to control organic diseases or infections, heart failure, etc.; Severe abnormal liver and kidney function (serum creatinine =1.5 times the normal value; ALT or AST=5 times the normal value; Bilirubin =1.5 times the normal value); (2) Patients with hematopoietic system diseases, such as anemia, need to use anemia correction drugs; (3) Patients who are receiving or are about to receive treatment that may have an impact on CRF; (4) People who are using drugs that may have an improving effect on CRF; (5) Those who suffer from mental illness and are unable to complete the scale assessment; (6) Subjects assessed by the investigator as unable to cooperate with the completion of the clinical investigation. Those who meet 1 or more of the above requirements are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS-R; | — |
Secondary
| Measure | Time frame |
|---|---|
| KPS;Patient satisfaction score;Patient compliance score; | — |
Countries
China
Contacts
Public ContactZhi-JieWang
Shanxi Province Hospital of Traditional Chinese Medicine
Outcome results
None listed